MedTrace Logo

Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy

NCT01125215 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-04-11

No results posted yet for this study

Summary

The objectives of this study are to determine efficacy and safety of 0.75% topical capsaicin nanoparticle preparation versus placebo in patient with painful diabetic neuropathy.

Conditions

  • Painful Diabetic Neuropathy

Interventions

DRUG

0.75% capsaicin nanoparticle cream

0.75% capsaicin nanoparticle cream apply to area with neuropathic pain twice daily for 12 weeks

DRUG

Placebo

Identical cream base of nanoparticle apply to area with neuropathic pain twice daily for 12 weeks

Sponsors & Collaborators

  • Thailand Research Fund

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Chuthamanee Suthisisang, PhD. · Faculty of Pharmacy,Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2013-10-31
Completion
2013-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01125215 on ClinicalTrials.gov